PATENT CLAIM ANALYSIS

Application Number: 16071610
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "019300"]

Abstract:
[Problem] To provide a highly safe and efficacious antitumor agent that is derived from probiotics. [Solution] The present invention relates to an antitumor agent comprising a compound represented by formula (1) or a complex thereof as an active ingredient. In formula (1): R 1  represents a hydrogen atom or a hydroxymethyl group; R 2  represents a hydrogen atom, a methyl group or a hydroxymethyl group; and R 3 , R 4  and R 5  each independently represent a methyl group, an N 5 -(trans-5-hydroxy-3-methylpent-2-enoyl) group, an N 5 -(cis-5-hydroxy-3-methylpent-2-enoyl) group or an N 5 -(trans-4-carboxy-3-methylpent-2-enoyl) group. According to the present invention, a highly safe and efficacious antitumor agent can be provided.

Claim (Index 5):
The method according to  claim 4 , wherein R 1  and R 2  are hydrogen atoms and R 3  to R 5  are methyl groups.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 95.0
- Lexical Diversity: 2.07463
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13576950', '14499201', '13576969', '15187179', '15821662']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7502794384835443
- 35 USC 102 Novelty (BERT): 0.5163329803768607
- Combined Prediction Score: 0.7268847926728759
- Mean Citation Score: 202.378726
- Max Citation Score: 231.51488
- Similarity Product: 127.52029231170654

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test